SPX 6,124.35 ▲ 0.47%DJI 44,210.18 ▼ 0.12%CCMP 19,875.02 ▲ 0.72%SX5E 5,231.77 ▲ 0.24%UKX 8,402.11 ▼ 0.22%NKY 39,870.50 ▲ 0.78%EURUSD 1.0842 ▼ 0.19%USGG10YR 4.31 ▲ 0.94%CL1 71.82 ▼ 0.88%XAU 2,685.40 ▲ 0.42%XBT 97,250.00 ▲ 1.93%SPX 6,124.35 ▲ 0.47%DJI 44,210.18 ▼ 0.12%CCMP 19,875.02 ▲ 0.72%SX5E 5,231.77 ▲ 0.24%UKX 8,402.11 ▼ 0.22%NKY 39,870.50 ▲ 0.78%EURUSD 1.0842 ▼ 0.19%USGG10YR 4.31 ▲ 0.94%CL1 71.82 ▼ 0.88%XAU 2,685.40 ▲ 0.42%XBT 97,250.00 ▲ 1.93%
 

← Persons Index

Zhu Yi
Rank #290 · Healthcare

Zhu Yi

Pharmaceuticals · China

Net worth$11.2B
Today−$149M
7 days−$51K
30 days−$172M

Net worth, last 30 days

Low $10.4BHigh $12.0B

Biography

Zhu Yi is the chairman of Biokin Pharmaceutical, a developer of drugs including anesthesia injections, cancer drugs as well as traditional Chinese medicine treatments.

The company went public in Shanghai in 2023, raising $136 million; it has been seeking a Hong Kong IPO since 2024.

Biokin's U.S. subsidiary SystImmune signed in 2023 an $8.4 billion deal with Bristol Myers Squibb to jointly develop and commercialize a potential cancer treatment worldwide.

Zhu taught immunology and microbiology at West China University of Medical Sciences before striking out on his own.

Did you know

Zhu has a master's in biology from Fudan University and a doctorate in management from Sichuan University.

Holdings

CompanyTickerSharesValue
Sichuan Biokin Pharmaceutical688506-CN299,060,000$75.4B
Private assets & other$23M

Public holdings ≈ $75.4B. Holdings may include options and overlap between rows.